Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing-Reference-Cited by-同舟云学术

Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing

Published:2014-04-10 Issue:4 Volume:10 Page:e1004071
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Wei Datsen George,Chiang Vicki,Fyne Elizabeth,Balakrishnan Mini,Barnes Tiffany,Graupe Michael,Hesselgesser Joseph,Irrinki Alivelu,Murry Jeffrey P.,Stepan George,Stray Kirsten M.,Tsai Angela,Yu Helen,Spindler Jonathan,Kearney Mary,Spina Celsa A.,McMahon Deborah,Lalezari Jacob,Sloan Derek,Mellors John,Geleziunas Romas,Cihlar Tomas

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference59 articles.

1. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial;E DeJesus;Lancet,2012

2. Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study;F Raffi;Lancet,2013

3. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy;S Palmer;Proc Natl Acad Sci U S A,2008

4. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy;TW Chun;Nat Med,2000

5. Randomized, controlled trial of therapy interruption in chronic HIV-1 infection;E Papasavvas;PLoS Med,2004

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and Development of HDAC Inhibitors: Approaches for the Treatment of Cancer a Mini-review;Current Drug Discovery Technologies;2024-11

2. HIV Persistence, Latency, and Cure Approaches: Where Are We Now?;Viruses;2024-07-19

3. Targeting Viral Transcription for HIV Cure Strategies;Microorganisms;2024-04-08

4. Eliminating the HIV tissue reservoir: current strategies and challenges;Infectious Diseases;2023-12-27

5. HIV-1 Gag co-localizes with euchromatin histone marks at the nuclear periphery;Journal of Virology;2023-12-21